The transmembrane receptor CD40 and its ligand (CD40L or CD154) are involved in initiating and sustaining the inflammatory response. While these responses are beneficial in infection and tumour lysis, chronic activation has been implicated in a range of neuroinflammatory and autoimmune conditions, including MS, Alzheimer’s disease and Parkinson’s disease. Read More